At the beginning of the pandemic, the world was desperate to find therapies that could improve outcomes in patients with COVID-19. The urgency brought repurposed drugs into the spotlight, but studies were poorly designed with many limitations and biases.

Clarissa Chan, PharmD

During residency at the University of Washington in Seattle, Traci White, PharmD, spent a lot of time on rotations in the ICU as part of the team providing intensive care to critically ill patients. What struck her about this work, she said, was “You’re looking at paper, numbers, data, and graphs. You’re talking a lot about the patient— you’re discussing everything about that patient. But you have no idea who that patient really is.”

Sonya Collins

According to CDC’s COVID-19 data tracker, as of press time, approximately 52% of the U.S. adult population was fully vaccinated against COVID-19, and 62.8% of U.S. adults have received at least one dose.¹  Vaccine uptake has continued to increase since the initial authorization in December 2020, but more recent data suggest that demand for the COVID-19 vaccine may be reaching a plateau.²

Maria G. Tanzi, PharmD

More than 150 million Americans have received at least one dose of a COVID-19 vaccine. Pharmacists have played a critical role in the effort it took to get this far. The crucial work of administering the vaccines, which pharmacists have done tirelessly, is just one piece of it. Pharmacists have also spent the last 7 months educating their patients, neighbors, and others about COVID-19 vaccines.

Sonya Collins

A new report from the American Heart Association (AHA) strongly links adverse pregnancy outcomes with a woman’s risk of developing cardiovascular disease (CVD).

Loren Bonner

The opioid epidemic continues to evolve. In addition to seeing more overdose cases attributed to fentanyl, officials in some U.S. states have noticed a significant uptick in a new, dangerous street drug detected in fatal overdose cases.

Loren Bonner

If you are wondering what health care disparities might look like in medication use for chronic diseases, a new study published in JAMA Network Open can serve as just one example.

Loren Bonner

On May 27, FDA expanded the indication for rimegepant (Nurtec ODT—Biohaven) to include preventive treatment in adults with episodic migraine, defined as fewer than 15 headache days per month.

Cara Aldridge Young

In today’s climate of self-management for optimal health and wellness, use of prebiotics and probiotics has become increasingly popular.

Daniel L. Krinsky, RPh, MS

Many patients with chronic pain turn to alternative, complementary therapy as part of their pain management. Acupuncture has been gaining legitimacy for decades and was approved as a medical therapy in the United States in the 1990s.

Mickie Cathers